CEFAMANDOLE PHARMACOKINETICS AND DOSAGE ADJUSTMENTS IN RELATION TO RENAL-FUNCTION

被引：4

作者：

BROGARD, JM ^{[1
]}

KOPFERSCHMITT, J ^{[1
]}

SPACH, MO ^{[1
]}

GRUDET, O ^{[1
]}

LAVILLAUREIX, J ^{[1
]}

机构：

[1] CTR HOSP UNIV STRASBOURG,INST HYG,F-67091 STRASBOURG,FRANCE

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1979年 / 19卷 / 07期

关键词：

D O I：

10.1002/j.1552-4604.1979.tb02493.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：366 / 377

页数：12

共 16 条

[1] PHARMACOKINETICS OF CEFAMANDOLE IN PATIENTS UNDERGOING HEMODIALYSIS AND PERITONEAL-DIALYSIS [J].

AHERN, MJ ;

FINKELSTEIN, FO ;

ANDRIOLE, VT .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 10 (03) :457-461

[2] PHARMACOKINETICS OF CEFAMANDOLE IN PRESENCE OF RENAL-FAILURE AND IN PATIENTS UNDERGOING HEMODIALYSIS [J].

APPEL, GB ;

NEU, HC ;

PARRY, MF ;

GOLDBERGER, MJ ;

JACOB, GB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 10 (04) :623-625

[3]

BROGARD JM, 1977, FUTURE TRENDS CHEMOT, V3, P39

[4]

BROGARD JM, 1976, B I PASTEUR, V74, P384

[5]

DETTLI L, 1971, ACTA PHARMACOL TOX, V29, P211

[6] ACTIVITY OF CEFAMANDOLE AND OTHER CEPHALOSPORINS AGAINST AEROBIC AND ANAEROBIC BACTERIA [J].

ERNST, EC ;

BERGER, S ;

BARZA, M ;

JACOBUS, NV ;

TALLY, FP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 9 (05) :852-855

[7]

EYKIN S, 1973, ANTIMICROBIAL AGENTS, V3, P657

[8]

FONG IW, 1976, ANTIMICROB AGENTS CH, V9, P65, DOI 10.1128/AAC.9.1.65

[9]

GRIFFITH RS, 1976, ANTIMICROB AGENTS CH, V10, P814, DOI 10.1128/AAC.10.5.814

[10]

GROSE WE, 1976, CLIN PHARMACOL THER, V20, P579

← 1 2 →